Cite
HARVARD Citation
Reiss, S. et al. (2017). Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas. Journal for immunotherapy of cancer. 5 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reiss, S. et al. (2017). Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas. Journal for immunotherapy of cancer. 5 (1), p. . [Online].